Quantitative studies of human urinary excretion of uropontin

Kidney International

Volumn 53, Issue 1, 1998, Pages 189-193

  Min, Wei ^a   Shiraga, Hiroshi ^a   Chalko, Charles ^a   Goldfarb, Stanley ^a   Krishna, G Gopal ^a   Hoyer, John R ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

Calcium oxalate crystals; Glycoprotein; Stone formation; Uropontin

Indexed keywords

ASPARTIC ACID; CALCIUM; CALCIUM OXALATE; CREATININE; ELECTROLYTE; GLYCOPROTEIN; PHOSPHORUS; POLYCLONAL ANTIBODY; PROTEIN; SODIUM; UNCLASSIFIED DRUG; UROPONTIN;

ADULT; ARTICLE; CIRCADIAN RHYTHM; CONTROLLED STUDY; DIETARY INTAKE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN EXPERIMENT; NORMAL HUMAN; PRIORITY JOURNAL; URINARY EXCRETION; URINE VOLUME; UROLITHIASIS;

EID: 0031912669     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1998.00745.x     Document Type: Article

References (24)

1. HERRING LC: Observations in the analysis of ten thousand urinary calculi. J Urol 88:545-555, 1962
2. COE FL, PARKS JH, ASPLIN JR: The pathogenesis and treatment of kidney stones. N Engl J Med 327:1141-1152, 1992
3. MEYER JL, SMITH LH: Growth of calcium oxalate crystals; II. Inhibition by natural urinary crystal growth inhibitors. Invest Urol 13:36-39, 1975
4. EDYVANE KA, HIBBERD CM, HARNETT RM, MARSHALL VR, RYALL RL: Macromolecules inhibit calcium oxalate crystal growth and aggregation in whole urine. Clin Chim Acta 167:329-338, 1987
5. LIESKE JC, LEONARD R, TOBACK FG: Adhesion of calcium oxalate monohydrate crystals to renal epithelial cells is inhibited by specific anions. Am J Physiol 268:F604-F612, 1995
6. FLEISCH H: Inhibitors and promotors of stone formation. Kidney Int 13:361-371, 1978
7. NAKAGAWA Y, ABRAM V, KEZDY FJ, KAISER ET, COE FL: Purification and characterization of the principal inhibitor of calcium oxalate monohydrate crystal growth in human urine. J Biol Chem 258:12594-12600, 1983
8. ASPLIN J, DEGANELLO S, NAKAGAWA Y, COE FL: Evidence that nephrocalcin and urine inhibit nucleation of calcium oxalate monohydrate crystals. Am J Physiol 261:F824-F830, 1991
9. HESS B, NAKAGAWA Y, COE FL: Inhibition of calcium oxalate monohydrate crystal aggregation by urine proteins. Am J Physiol 257:F99-F106, 1989
10. SHIRAGA H, MIN W, VANDUSEN WJ, CLAYMAN MD, MINER D, TERRELL CH, SHERBOTIE JR, FOREMAN JW, PRZYSIECKI C, NEILSON EG, HOYER JR: Inhibition of calcium oxalate crystal growth in vitro by uropontin: Another member of the aspartic acid-rich protein superfamily. Proc Natl Acad Sci USA 89:426-430, 1992
11. ASPLIN JR, ARSENAULT D, PARKS JH, COE FL, HOYER JR: Contribution of human uropontin to urine inhibition of calcium oxalate crystallization. Kidney Int 53:194-199, 1997
12. HOYER JR, OTVOS L JR, URGE L: Osteopontin in urinary stone formation. Ann N Y Acad Sci 760:257-265, 1995
13. WORCESTER EM, BLUMENTHAL SS, BESHENSKY A: The calcium oxalate crystal growth inhibitor protein produced by mouse kidney cortical cells in culture is osteopontin. J Bone Miner Res 7:1029-1036, 1992
14. WORCESTER EM, BESHENSKY AM: Osteopontin inhibits nucleation of calcium oxalate crystals. Ann N Y Acad Sci 760:375-377, 1995
15. HOYER JR, WIKOFF W, BOCK SC: Selective incorporation of uropontin into urinary calcium oxalate monohydrate stones. (abstract) J Am Soc Nephrol 3:684, 1992
16. KOHRI K, SUZUKI Y, YOSHIDA K, YAMAMOTO K, AMASAKI N, YAMATE T, UMEKAWA T, IGUCHI M, SINOHARA H, KURITA T: Molecular cloning and sequencing of cDNA encoding urinary stone protein, which is identical to osteopontin. Biochem Biophys Res Comm 184: 859-864, 1992
17. MCKEE MD, NANCI A, KHAN SR: Ultrastructural immunodetection of osteopontin and osteocalcin as major matrix components of renal calculi. J Bone Miner Res 10:1913-1929, 1995
18. LOPEZ CA, HOYER JR, WILSON PD, WATERHOUSE P, DENHARDT DT: Heterogeneity of osteopontin expression among nephrons in mouse kidneys and enhanced expression in sclerotic glomeruli. Lab Invest 69:355-363, 1993
19. KLEINMAN JG, BESHENSKY A, WORCESTER EM, BROWN D: Expression of osteopontin, a urinary inhibitor of stone mineral crystal growth, in rat kidney. Kidney Int 47:1585-1596, 1995
20. MADSEN KM, ZHANG L, SHAMAT A-RA, SIEGFRIED S, CHA J-H: Ultrastructural localization of osteopontin in the kidney: Induction by lipopolysaccharide. J Am Soc Nephrol 8:1043-1053, 1997
21. BROWN LF, BERSE B, VANDEWATER L, PAPADOPOULOS-SERGIOU A, PERRUZZI CA, MANSEAU EJ, DVORAK HF, SENGER DR: Expression and distribution of osteopontin in human tissues; widespread association with luminal epithelial surfaces. Molec Biol Cell 3:1168-1180, 1992
22. KOHRI K, NOMURA S, KITAMURA Y, NAGATA T, YOSHIOKA K, IGUCHI M, YAMATE T, UMEKAWA T, SUZUKI Y, SINOHARA H: Structure and expression of the mRNA encoding urinary stone protein (osteopontin). J Biol Chem 268:15180-15184, 1993
23. LIESKE JC, HAMMES MS, HOYER JR, TOBACK FG: Renal cell osteopontin production is stimulated by calcium oxalate monohydrate crystals. Kidney Int 51:679-686, 1997
24. WASSERSTEIN A, STOLLEY P, GOLDFARB S, AGUS Z: Case control study of risk factors for nephrolithiasis. Miner Electrolyte Metnb 13:85-95, 1987